Michael Mejia
@mikemejiamd
Followers
834
Following
4K
Media
74
Statuses
3K
Chair, Department of Radiation Oncology University of Santo Tomas Hospital. Head and Neck Unit BCI Tweets are my own.
Manila City, National Capital
Joined May 2010
This is why patients cannot be customers https://t.co/Cgftqw0BdN via @kevinmd #healthxph #radonc nuff said.
kevinmd.com
Health is our most valuable asset, not comparable to a sweater or a bowl of soup.
0
1
6
Such a pleasure and honor to work with this team in coming up with these landmark papers. With authors from across the globe with a wide spectrum of viewpoints from high to #lmic #radonc backgrounds https://t.co/Y5cWUckCXt
https://t.co/yU7fYYvhwC
0
1
2
Spent the early morning discussing about #HeadNeckCancer research on campus #NCCS Prof Darren Lim sharing on an #APAC specific #ClinicalTrials network for HeadNeckCancer @H_N_C_I_G
@lachiemcd
@mikemejiamd
@kiyota_naomi
@DrGopalIyer
@sophiawongyn
1
6
18
📜 In #Laryngoscope, led by @jennych7799, we report the burden of #head and #neck #cancers in #Southeast #Asia 🇹🇭🇵🇭🇮🇩🇻🇳🇰🇭🇲🇲🇲🇾🇹🇱🇧🇳🇱🇦🇸🇬 🙏 Grateful to our team! @MikeMejiaMD @IMRTLee @DrMLChua @LuisaJacomina @Erin_Feliciano @Jonas_Willmann @JamesFanWu 🔗 https://t.co/7WYGmMO3tw
1
9
19
What a #Legend He was one of the few who always kept it FUN and REAL and left a lasting impression when I first heard him speak at @ASTRO_org Annual Meeting @a_dalpra @aleberlin2 @DrSpratticus @VedangMurthy @seanmmcbride @drkevin_chua_lm @mikemejiamd @_ShankarSiva
📢Special day: Literally Dr. Anthony Zietman's Last Day in #radonc clinic😳🥳😔 After 3️⃣9️⃣ years of service🙏🙏🙏 Handing the torch 🔥(for the clinic space that is😉) to @sophia_kamran 😅 A loss for our field, but he is going out on top‼️⛰️ @sueyom
3
4
25
Still of the conviction that most #nasopharyngealcarcinoma is best treated by upfront CCRT so would’ve been an outlier vote here. ACT with cape or GP for high risk.
Interesting poll from #NasopharyngealCarcinoma Meeting in Guangzhou among Chinese Experte What should be the SOC for high-risk NPC trial? @imrtlee @Qle_stanford @sueyom @mikemejiamd @lachiemcd @Larvol @oncodaily In case translation is needed, option 1 is IC+CRT and option 2
0
0
4
Questions hopefully answered
📢This might just be THE DEFINITIVE meta-analysis of PSMA PET for #prostatecancer recurrence. 🚨Meta-analysis of 43 studies (n=8,119) ⬆️Sensitivity from 48% at PSA 0.2–0.5 ng/ml to >90% at PSA >2. Congrats @declangmurphy @drMPerera + team @Uroweb! ➡️link https://t.co/VYvAn6kli1
0
0
0
Regional nodal irradiation in negative nodal status and after primary systemic therapy - amazing teaching lecture by Philip Poortmans and Liesbeth Boersma #ESTRO25
#radonc #breastcancer @OncoAlert #OncoAlert
4
42
95
We’re honored to have our work featured by ASTRO! What started as a determined effort in resource-limited settings has grown into something we’re truly proud of. We hope to bridge important knowledge gaps in the understanding and management of #NPC
@WarrenBacorro @DrMLChua
New in #practicalRO: International Consensus Guidelines on the Delineation of Radiation Therapy Target Volumes for Nasopharyngeal Carcinoma After Induction Chemotherapy Using a 2-Round Modified Delphi Survey #radonc
https://t.co/GsWRRlCZ4N
0
0
3
First of 2 consensus statements coming out for #NPC. This one is an effort undertaken with most of the participants from #LMIC settings. Excellent inclusivity effort from @WarrenBacorro and team. https://t.co/b8KBnquYgP
0
3
4
Future directions in #hncsm is #SBRT. Not new in NPC as it was part of our reRT cohort ( https://t.co/s8Bg7JNE2Q), but it may be time to increase breadth and depth
ascopubs.org
PURPOSEThe objectives of this study were to report the oncologic outcomes and the treatment-related toxicities after reirradiation (re-RT) for recurrent nasopharyngeal carcinoma (rNPC) at our...
Beauty of #AcademicMedicine is so that people from around the world can brainstorm on care of patients. Happy that we can share our experience with #SRS #SBRT for #HeadNeckCancer #NPC patients, in this case a young lady from Romania! @mikemejiamd Makes my day and perhaps the
1
1
2
Expanding the role of SABR in #headandneckcancer is always both challenging and exciting. Kudos to GORTEC
Hot of the press @IJROBP: Role of SABR in oligometastatic head and neck cancer: a GORTEC randomized trial Full text here: https://t.co/MuEI1uURxQ
0
2
9
Grateful to Dr @LuisaJacomina and our entire team Dr @MikeMejiaMD, Dr Cherry Estilo, Dr Gelo Militante, Dr Ian Fernando, and Dr Sandy Uy for promoting #oral #oncology #education in the #Philippines 🇵🇭 Some tough cases today needing true multidisciplinary collaboration! 🤝
0
4
9
#hncsm #npc It’s time to have that conversation of reducing toxicity for select patients. Volume reduction may be one avenue to achieve this the more we know about the behavior of the disease @WarrenBacorro @luisajacomina @EChrisDee
This may not be "practice-changing" per se but kudos to the investigators for running this trial. I have known Prof Tang for many years now and she is a solid clinician who has prob treated more #NPC than most of us (even experts) around the world! Look out for more
0
3
11
The @USTFMSofficial and #Philippine #Dental Association #oral #oncology seminar series 🇵🇭 Dr @MikeMejiaMD's introduction to HN #radiation ☢️ fostering #multidisciplinary collaboration with over 200 #dental 🦷 #medical ⚕️ and allied attendees from all over the Philippines 🙏
0
3
4
Fantastic summary of MDT trials and directions in OMBC! Key question to our #bcsm #radonc #sbrt folks: DOES an oligometastatic state exist in breast cancer? @luisajacomina @IBCradiation @SFShaitelmanMD @CJTsaiMDPhD @drdavidpalma
🧵 SBRT in Oligometastatic Breast Cancer: What does the evidence show? A summary of key studies and their impact on survival. Let’s dive in! 👇 1/ What is Oligometastatic Breast Cancer (OMBC)? OMBC is an intermediate state between localized and widespread metastatic disease,
1
0
4
Brilliant explanations below 👇
My brilliant med student asked me to explain correlation, causation, confounding &collider bias. I used the following ex… so sharing here in case anyone finds it helpful! PS -I have learned much from @dnunan79 @Catalogofbias - a great resource for EBM. hopefully he approves😅
0
0
0
My brilliant med student asked me to explain correlation, causation, confounding &collider bias. I used the following ex… so sharing here in case anyone finds it helpful! PS -I have learned much from @dnunan79 @Catalogofbias - a great resource for EBM. hopefully he approves😅
86
1K
7K
👏👏👏
In today’s @QuadShotNews and now on @IJROBP as pre-proof‼️ Excited to share our study on palliative RT for breast cancer @MDAndersonNews 💖RT is effective in palliating symptoms from LABC 💕More RT isn’t always better (or necessary?) 💘QOL is 🔑 https://t.co/MrRUYWAzuJ
0
0
1